How a black Turkish woman mesmerised millions of hearts by her songs, shooting to fame in the 70s
Turkey is home to many people of African descent, and there are many Afro-Turks who have achieved success in various fields — from science to military to music. Esmeray Diriker was one of the shining stars of the community, whose mesmerising voice - layered with melancholy and longing - touched millions of hearts.
At the tender age of 11, Esmeray started her career as a theatre performer in 1960. She performed in child theatre for five years at Istanbul City Theatres, and played in several famous theatres until 1974. In 1978, Esmeray, along with Ertan Anapa, Funda Anapa, Melike Demirag, Kerem Yilmazer and Iskender Doganay founded a group called ‘Grup Sekstet’ and finished in second place with their song called ‘Insaniz Biz’ at the Eurovision Song Contest.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
‘Bill & Ted Face The Music’: Keanu Reeves & Alex Winter Meet Their Future Selves In Debut TrailerHere’s the first trailer for Bill & Ted Face The Music, which is set to see Keanu Reeves and Alex Winter return for a long awaited sequel to their cult time travel movies. In the threeque…
続きを読む »
Meet the 3 Women Who Founded the Black Lives Matter MovementPatrisse Cullors, Alicia Garza and Opal Tometi started with social media in the wake of the not-guilty verdict for the man who killed 17-year-old Trayvon Martin and prompted a cultural reckoning
続きを読む »
US and Russia to meet for nuclear arms negotiations this monthUS and Russian officials will meet later this month for nuclear arms negotiations, a top US arms control official announced Monday.
続きを読む »
'90 Day Fiancé': David's Been to Ukraine Over 20 Times to Meet WomenDavid's relationship with his Ukrainian girlfriend, Lana, both astonished and confused his fellow castmates.
続きを読む »
Merck's Keytruda doesn't meet goals in bladder cancer studyMerck Inc. said late Tuesday that its drug Keytruda did not reach its goals in a late-stage clinical study for the treatment of bladder cancer. The drug maker said bladder cancer patients given Keytruda in a Phase 3 clinical study did not show a statistically significant improvement in overall survival or progression-free survival compared with patients given standard chemotherapy. Keytruda is already approved to treat several other types of cancer. In 2019, Merck reported Keytruda sales made up $11.08 billion of its $46.84 billion in sales. Merck shares rose 0.3% after hours, following a 0.7% decline to close the regular session at $82.26.
続きを読む »
Meet Greg Glassman, CrossFit CEO under fire for George Floyd comments - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »